"Antihypertensive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
| Descriptor ID |
D000959
|
| MeSH Number(s) |
D27.505.954.411.162
|
| Concept/Terms |
Antihypertensive Agents- Antihypertensive Agents
- Agents, Antihypertensive
- Antihypertensives
- Anti-Hypertensives
- Anti Hypertensives
- Antihypertensive Drugs
- Drugs, Antihypertensive
- Anti-Hypertensive Agents
- Agents, Anti-Hypertensive
- Anti Hypertensive Agents
- Anti-Hypertensive Drugs
- Anti Hypertensive Drugs
- Drugs, Anti-Hypertensive
|
Below are MeSH descriptors whose meaning is more general than "Antihypertensive Agents".
Below are MeSH descriptors whose meaning is more specific than "Antihypertensive Agents".
This graph shows the total number of publications written about "Antihypertensive Agents" by people in this website by year, and whether "Antihypertensive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 1 | 2 | 3 |
| 2004 | 2 | 0 | 2 |
| 2005 | 2 | 2 | 4 |
| 2006 | 0 | 4 | 4 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 2 | 3 |
| 2009 | 2 | 3 | 5 |
| 2010 | 2 | 1 | 3 |
| 2011 | 7 | 1 | 8 |
| 2012 | 6 | 2 | 8 |
| 2013 | 6 | 3 | 9 |
| 2014 | 7 | 1 | 8 |
| 2015 | 4 | 4 | 8 |
| 2016 | 5 | 3 | 8 |
| 2017 | 5 | 3 | 8 |
| 2018 | 2 | 0 | 2 |
| 2019 | 3 | 1 | 4 |
| 2020 | 3 | 3 | 6 |
| 2021 | 3 | 0 | 3 |
| 2022 | 1 | 6 | 7 |
| 2023 | 0 | 2 | 2 |
| 2024 | 3 | 3 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antihypertensive Agents" by people in Profiles.
-
Trends in Initial Antihypertensive Medication Prescribing Among >2.8?Million Veterans Newly Diagnosed With Hypertension, 2000 to 2019. J Am Heart Assoc. 2024 Oct 15; 13(20):e036557.
-
Blood Pressure Reduction and Changes in Antihypertensive Medication Use Among Patients With Hypertension Who Initiated Sodium-Glucose Cotransporter-2 Inhibitors. J Clin Hypertens (Greenwich). 2024 Nov; 26(11):1318-1321.
-
Trends of Antihypertensive Prescription Among US Adults From 2010 to 2019 and Changes Following Treatment Guidelines: Analysis of Multicenter Electronic Health Records. J Am Heart Assoc. 2024 May 07; 13(9):e032197.
-
Hypertension, Cardiovascular Risk Factors, and Uterine Fibroid Diagnosis in Midlife. JAMA Netw Open. 2024 Apr 01; 7(4):e246832.
-
Antihypertensive medication persistence and adherence among non-Hispanic Asian US patients with hypertension and fee-for-service Medicare health insurance. PLoS One. 2024; 19(3):e0300372.
-
Sitting Time Reduction and Blood Pressure in Older Adults: A Randomized Clinical Trial. JAMA Netw Open. 2024 03 04; 7(3):e243234.
-
Relationship of Blood Pressure, Health Behaviors, and New Diagnosis and Control of Hypertension in the BP-CHECK Study. Circ Cardiovasc Qual Outcomes. 2024 02; 17(2):e010119.
-
Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes. Am J Nephrol. 2023; 54(7-8):258-267.
-
Hypertension care during the COVID-19 pandemic in an integrated health care system. J Clin Hypertens (Greenwich). 2023 Apr; 25(4):315-325.
-
Comparing Pharmacist-Led Telehealth Care and Clinic-Based Care for Uncontrolled High Blood Pressure: The Hyperlink 3 Pragmatic Cluster-Randomized Trial. Hypertension. 2022 12; 79(12):2708-2720.